The 60th Global Annual Meeting of DIA will bring together thousands of stakeholders in industry, regulators, academics, and patients.

Lumanity will be presenting and attending the global meeting and encourage you to join our colleagues in San Diego.

Long-term safety of approved medicines: approaches for identifying, characterizing, and quantifying delayed adverse events
June 18, 10:00-11:00AM

– Steven Weisman, Global President, Clinical and Regulatory, Lumanity
– Naomi Boxall, General Manager, PHARMO Institute
– Gerald Dal Pan, Director, Office of Surveillance and Epidemiology, CDER, FDA
– Vera Ehrenstein, Professor, Department of Clinical Medicine, Dept of Clinical Epidemiology, Aarhus University
– Claudia Salinas, Senior Director, GPS Pharmacoepidemiology, Eli Lilly and Company

Read our recent article, Long follow-up in short supply: the need for multi-setting, clinically rich longitudinal real world data, here.

Connect with our staff or schedule a time to meet during the meeting by reaching out to